Breaking News Instant updates and real-time market news.

CLSN

Celsion

$2.12 /

+0.06 (+2.91%)

08:55
03/02/21
03/02
08:55
03/02/21
08:55

Celsion announces poster presentation on Phase I/II OVATION 2 study

Celsion Corporation announced that a poster on the Company's Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian cancer has been accepted for presentation at the Virtual Annual Meeting on Women's Cancer, sponsored by the Society of Gynecologic Oncology. The conference is being held March 19-25, 2021. The OVATION 2 Study design is being presented as a poster entitled "A Phase I/II Study Evaluating Intraperitoneal GEN-1 in Combination with Neoadjuvant Chemotherapy in Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer" in the "Trials in Progress" poster session from March 19 to 25. GEN-1 is Celsion's DNA-mediated interleukin-12 immunotherapy designed using TheraPlas, its proprietary, synthetic, non-viral nanoparticle delivery system platform. The poster describes the OVATION 2 Study, which combines GEN-1 with standard-of-care neoadjuvant chemotherapy (NACT) in patients newly diagnosed with Stage III/IV ovarian cancer. NACT is designed to shrink the cancer as much as possible for optimal surgical removal after three cycles of chemotherapy. Following NACT, patients undergo interval debulking surgery, followed by three adjuvant cycles of chemotherapy and up to nine additional weekly GEN-1 treatments, the goal of which is to delay progression and improve overall survival. The OVATION 2 Study is an open-label, 1-to-1 randomized trial, 80% powered to show the equivalent of a 33% improvement in progression-free survival, the primary endpoint, when comparing the treatment arm with the control arm. The Company recently announced that to date it has enrolled approximately one-third, or 34 patients, of the anticipated 110 patients to be enrolled into the OVATION 2 Study, of which 20 are in the treatment arm and 14 are in the control. Currently, 28 patients have had their interval debulking surgery with the following results: 13 of 16, or 81%, of patients treated with GEN-1 had a R0 resection, which indicates a microscopically margin-negative complete resection in which no gross or microscopic tumor remains in the tumor bed. 7 of 12 patients, or 58%, of patients in the control arm had an R0 resection. This interim data represents a 40% improvement in R0 resection rates for GEN-1- patients compared with control arm patients and is consistent with the reported improvement in resection scores noted in the encouraging Phase I OVATION 1 Study, the manuscript of which has been submitted for peer review publication. Celsion also announced last week that GEN-1 had received Fast Track designation from the U.S. Food and Drug Administration. This designation is intended to facilitate the development and expedite the regulatory review of drugs to treat serious conditions and fill an unmet medical need.

CLSN Celsion
$2.12 /

+0.06 (+2.91%)

07/16/20 Oppenheimer
Celsion downgraded to Perform at Oppenheimer
07/16/20 Oppenheimer
Celsion downgraded to Perform from Outperform at Oppenheimer
07/14/20 Dawson James
Celsion downgraded to Hold from Buy at Dawson James

TODAY'S FREE FLY STORIES

Recommendations
Snap price target lowered to $72 from $74 at Deutsche Bank » 06:54
04/23/21
04/23
06:54
04/23/21
06:54
SNAP

Snap

$57.12 /

-1.17 (-2.01%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$57.12 /

-1.17 (-2.01%)

SNAP Snap
$57.12 /

-1.17 (-2.01%)

06:44 Today KeyBanc
Snap price target lowered to $80 from $87 at KeyBanc
04:53 Today Piper Sandler
Piper reiterates $83 target on Snap, says long-term thesis unchanged
04/20/21 MKM Partners
Snap positioned for beat and in-line quarter, says MKM Partners
04/19/21 JPMorgan
JPMorgan remains positive on Snap into Q1 results
SNAP Snap
$57.12 /

-1.17 (-2.01%)

SNAP Snap
$57.12 /

-1.17 (-2.01%)

SNAP Snap
$57.12 /

-1.17 (-2.01%)

SNAP Snap
$57.12 /

-1.17 (-2.01%)

Hot Stocks
Schlumberger 'encouraged by constructive macroeconomic drivers' » 06:54
04/23/21
04/23
06:54
04/23/21
06:54
SLB

Schlumberger

$25.25 /

-0.48 (-1.87%)

Schlumberger CEO Olivier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

04/19/21 BMO Capital
Baker Hughes upgraded to Outperform from Market Perform at BMO Capital
03/02/21 Barclays
Schlumberger price target raised to $35 from $31 at Barclays
02/01/21 BofA
US 1 List changes at BofA
02/01/21 Piper Sandler
Schlumberger price target raised to $25 from $18 at Piper Sandler
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

Hot Stocks
Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe » 06:54
04/23/21
04/23
06:54
04/23/21
06:54
BMY

Bristol-Myers

$66.32 /

+ (+0.00%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

Recommendations
Carnival price target raised to $18 from $14 at Morgan Stanley » 06:53
04/23/21
04/23
06:53
04/23/21
06:53
CCL

Carnival

$26.92 /

-0.41 (-1.50%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$26.92 /

-0.41 (-1.50%)

CCL Carnival
$26.92 /

-0.41 (-1.50%)

04/21/21 Berenberg
Carnival price target raised to $20 from $14 at Berenberg
04/21/21 Goldman Sachs
Carnival price target raised to $26 from $21 at Goldman Sachs
04/20/21 Macquarie
Carnival demand strong despite uncertain U.S. restart, says Macquarie
04/09/21
Fly Intel: Top five analyst upgrades
CCL Carnival
$26.92 /

-0.41 (-1.50%)

  • 23
    Feb
CCL Carnival
$26.92 /

-0.41 (-1.50%)

CCL Carnival
$26.92 /

-0.41 (-1.50%)

CCL Carnival
$26.92 /

-0.41 (-1.50%)

Hot Stocks
Becton Dickinson to provide rapid COVID-19 testing to USA Track & Field » 06:53
04/23/21
04/23
06:53
04/23/21
06:53
BDX

Becton Dickinson

$257.03 /

-1.09 (-0.42%)

USA Track & Field, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$257.03 /

-1.09 (-0.42%)

BDX Becton Dickinson
$257.03 /

-1.09 (-0.42%)

04/05/21 Argus
Weaker demand for Covid testing solutions to weigh on BD, says Argus
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/12/21 Wells Fargo
Wells Fargo sees only 'small chance' of positive FDA panel for Becton
02/05/21 Citi
Becton Dickinson price target raised to $280 from $273 at Citi
BDX Becton Dickinson
$257.03 /

-1.09 (-0.42%)

  • 21
    May
BDX Becton Dickinson
$257.03 /

-1.09 (-0.42%)

Recommendations
Royal Caribbean price target raised to $61 from $50 at Morgan Stanley » 06:53
04/23/21
04/23
06:53
04/23/21
06:53
RCL

Royal Caribbean

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
/

+

RCL Royal Caribbean
/

+

04/21/21 Berenberg
Royal Caribbean price target raised to $70 from $55 at Berenberg
04/21/21 Goldman Sachs
Royal Caribbean price target raised to $95 from $76 at Goldman Sachs
03/24/21 Stifel
Cruiseline stock selloff 'unwarranted,' says Stifel
03/18/21 UBS
Royal Caribbean price target raised to $116 from $79 at UBS
RCL Royal Caribbean
/

+

  • 01
    Mar
  • 14
    Oct
RCL Royal Caribbean
/

+

RCL Royal Caribbean
/

+

RCL Royal Caribbean
/

+

Recommendations
Olo price target raised to $35 from $32 at RBC Capital » 06:53
04/23/21
04/23
06:53
04/23/21
06:53
OLO

Olo

$29.95 /

+1.62 (+5.72%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLO Olo
$29.95 /

+1.62 (+5.72%)

OLO Olo
$29.95 /

+1.62 (+5.72%)

04/12/21
Fly Intel: Top five analyst initiations
04/12/21 William Blair
Olo initiated with an Outperform at William Blair
04/12/21 Truist
Truist starts Olo with a Buy, sees sustained 30% or more growth potential
04/12/21 JPMorgan
Olo initiated with an Overweight at JPMorgan
  • 17
    Mar
OLO Olo
$29.95 /

+1.62 (+5.72%)

OLO Olo
$29.95 /

+1.62 (+5.72%)

OLO Olo
$29.95 /

+1.62 (+5.72%)

Recommendations
Seagate price target raised to $83 from $78 at Mizuho » 06:52
04/23/21
04/23
06:52
04/23/21
06:52
STX

Seagate

$84.14 /

+0.19 (+0.23%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

06:45 Today Morgan Stanley
Seagate price target raised to $98 from $90 at Morgan Stanley
06:37 Today Citi
Seagate price target raised to $85 from $75 at Citi
04/21/21 Loop Capital
Seagate price target raised to $100 from $90 at Loop Capital
04/08/21 Morgan Stanley
Seagate price target raised to $90 from $86 at Morgan Stanley
STX Seagate
$84.14 /

+0.19 (+0.23%)

  • 04
    Mar
STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

Recommendations
Site Centers price target raised to $15 from $13 at Mizuho » 06:52
04/23/21
04/23
06:52
04/23/21
06:52
SITC

Site Centers

$14.29 /

-0.175 (-1.21%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SITC Site Centers
$14.29 /

-0.175 (-1.21%)

SITC Site Centers
$14.29 /

-0.175 (-1.21%)

03/31/21 Truist
Site Centers price target raised to $13 from $11 at Truist
03/04/21 KeyBanc
Site Centers upgraded to Overweight at KeyBanc
03/04/21 KeyBanc
Site Centers upgraded to Overweight from Sector Weight at KeyBanc
02/23/21 Mizuho
Site Centers price target raised to $13 from $10.50 at Mizuho
SITC Site Centers
$14.29 /

-0.175 (-1.21%)

  • 02
    Mar
Hot Stocks
Schlumberger reports Q1 cash flow from operations $429M, free cash flow $159M  06:51
04/23/21
04/23
06:51
04/23/21
06:51
SLB

Schlumberger

$25.25 /

-0.48 (-1.87%)

 
ShowHide Related Items >><<
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

04/19/21 BMO Capital
Baker Hughes upgraded to Outperform from Market Perform at BMO Capital
03/02/21 Barclays
Schlumberger price target raised to $35 from $31 at Barclays
02/01/21 BofA
US 1 List changes at BofA
02/01/21 Piper Sandler
Schlumberger price target raised to $25 from $18 at Piper Sandler
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

Recommendations
Iqvia price target raised to $250 from $218 at Mizuho » 06:51
04/23/21
04/23
06:51
04/23/21
06:51
IQV

Iqvia

$225.98 /

+6.9 (+3.15%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IQV Iqvia
$225.98 /

+6.9 (+3.15%)

IQV Iqvia
$225.98 /

+6.9 (+3.15%)

06:39 Today Citi
Iqvia price target raised to $265 from $225 at Citi
04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Stephens
Iqvia upgraded to Overweight with $250 price target at Stephens
04/16/21 Stephens
Iqvia upgraded to Overweight from Equal Weight at Stephens
IQV Iqvia
$225.98 /

+6.9 (+3.15%)

IQV Iqvia
$225.98 /

+6.9 (+3.15%)

IQV Iqvia
$225.98 /

+6.9 (+3.15%)

Earnings
Schlumberger reports Q1 adjusted EPS 21c, consensus 19c » 06:50
04/23/21
04/23
06:50
04/23/21
06:50
SLB

Schlumberger

$25.25 /

-0.48 (-1.87%)

Reports Q1 revenue $5.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

04/19/21 BMO Capital
Baker Hughes upgraded to Outperform from Market Perform at BMO Capital
03/02/21 Barclays
Schlumberger price target raised to $35 from $31 at Barclays
02/01/21 BofA
US 1 List changes at BofA
02/01/21 Piper Sandler
Schlumberger price target raised to $25 from $18 at Piper Sandler
SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

SLB Schlumberger
$25.25 /

-0.48 (-1.87%)

Recommendations
Tractor Supply price target raised to $190 from $170 at Morgan Stanley » 06:50
04/23/21
04/23
06:50
04/23/21
06:50
TSCO

Tractor Supply

$188.30 /

+8.075 (+4.48%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSCO Tractor Supply
$188.30 /

+8.075 (+4.48%)

TSCO Tractor Supply
$188.30 /

+8.075 (+4.48%)

04/22/21 Baird
Tractor Supply price target raised to $210 from $200 at Baird
04/19/21 Baird
Tractor Supply price target raised to $200 from $180 at Baird
04/19/21 Wedbush
Tractor Supply price target raised to $180 from $145 at Wedbush
04/19/21 Piper Sandler
Tractor Supply price target raised to $203 from $175 at Piper Sandler
TSCO Tractor Supply
$188.30 /

+8.075 (+4.48%)

TSCO Tractor Supply
$188.30 /

+8.075 (+4.48%)

TSCO Tractor Supply
$188.30 /

+8.075 (+4.48%)

Recommendations
HCA Healthcare price target raised to $232 from $205 at Mizuho » 06:50
04/23/21
04/23
06:50
04/23/21
06:50
HCA

HCA Healthcare

$201.52 /

+3.96 (+2.00%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

06:45 Today RBC Capital
HCA Healthcare price target raised to $232 from $205 at RBC Capital
04/14/21 Truist
HCA Healthcare price target raised to $230 from $200 at Truist
04/13/21 Deutsche Bank
HCA Healthcare price target raised to $210 from $180 at Deutsche Bank
04/09/21 Mizuho
HCA Healthcare price target raised to $205 from $195 at Mizuho
HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

Recommendations
Danaher price target raised to $280 from $260 at Wells Fargo » 06:49
04/23/21
04/23
06:49
04/23/21
06:49
DHR

Danaher

/

+

Wells Fargo analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHR Danaher
/

+

DHR Danaher
/

+

06:42 Today KeyBanc
Danaher price target raised to $315 from $280 at KeyBanc
06:41 Today RBC Capital
Danaher price target raised to $285 from $253 at RBC Capital
06:32 Today Citi
Danaher price target raised to $315 from $275 at Citi
04/08/21 Citi
Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat
DHR Danaher
/

+

  • 08
    May
DHR Danaher
/

+

DHR Danaher
/

+

Upgrade
Cimarex Energy upgraded to Strong Buy from Outperform at Raymond James » 06:49
04/23/21
04/23
06:49
04/23/21
06:49
XEC

Cimarex Energy

$60.88 /

+0.01 (+0.02%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XEC Cimarex Energy
$60.88 /

+0.01 (+0.02%)

XEC Cimarex Energy
$60.88 /

+0.01 (+0.02%)

04/22/21 MKM Partners
Cimarex Energy upgraded to Buy from Neutral at MKM Partners
04/20/21 Mizuho
Cimarex Energy price target raised to $90 from $76 at Mizuho
04/15/21 Scotiabank
Cimarex Energy upgraded to Outperform amid sector rating shake-up at Scotiabank
04/15/21 Scotiabank
Cimarex Energy upgraded to Outperform from Sector Perform at Scotiabank
XEC Cimarex Energy
$60.88 /

+0.01 (+0.02%)

XEC Cimarex Energy
$60.88 /

+0.01 (+0.02%)

Upgrade
Continental Resources upgraded to Outperform from Market Perform at Raymond James » 06:49
04/23/21
04/23
06:49
04/23/21
06:49
CLR

Continental Resources

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLR Continental Resources
/

+

CLR Continental Resources
/

+

04/20/21 Mizuho
Continental Resources price target raised to $29 from $28 at Mizuho
03/24/21 MKM Partners
Continental Resources upgraded to Buy at MKM Partners on valuation
03/24/21 MKM Partners
Continental Resources upgraded to Buy from Neutral at MKM Partners
03/23/21 Goldman Sachs
Continental Resources assumed with a Sell at Goldman Sachs
CLR Continental Resources
/

+

CLR Continental Resources
/

+

Downgrade
Range Resources downgraded to Underperform from Market Perform at Raymond James » 06:48
04/23/21
04/23
06:48
04/23/21
06:48
RRC

Range Resources

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RRC Range Resources
/

+

RRC Range Resources
/

+

04/20/21 Mizuho
Range Resources price target lowered to $11 from $13 at Mizuho
03/23/21 Goldman Sachs
Range Resources assumed with a Sell at Goldman Sachs
03/23/21 Citi
Range Resources price target raised to $10.50 from $7.50 at Citi
03/15/21 Piper Sandler
Range Resources price target raised to $9 from $8 at Piper Sandler
RRC Range Resources
/

+

RRC Range Resources
/

+

RRC Range Resources
/

+

Downgrade
Southwestern Energy downgraded to Underperform from Market Perform at Raymond James » 06:48
04/23/21
04/23
06:48
04/23/21
06:48
SWN

Southwestern Energy

$4.02 /

+0.075 (+1.90%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWN Southwestern Energy
$4.02 /

+0.075 (+1.90%)

SWN Southwestern Energy
$4.02 /

+0.075 (+1.90%)

04/20/21 Mizuho
Southwestern Energy price target raised to $5 from $4 at Mizuho
03/23/21 Goldman Sachs
Southwestern Energy assumed with a Buy at Goldman Sachs
03/23/21 Citi
Southwestern Energy price target raised to $4.75 from $3.50 at Citi
03/08/21 Johnson Rice
Southwestern Energy upgraded to Buy from Hold at Johnson Rice
SWN Southwestern Energy
$4.02 /

+0.075 (+1.90%)

  • 14
    Aug
SWN Southwestern Energy
$4.02 /

+0.075 (+1.90%)

Hot Stocks
Cathie Wood's ARK Investment discloses another 1.2M shares of Skillz bought » 06:48
04/23/21
04/23
06:48
04/23/21
06:48
SKLZ

Skillz

$16.62 /

-0.13 (-0.78%)

Shares of Skillz are up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

04/22/21 Jefferies
Skillz initiated with a Hold at Jefferies
03/25/21 Stifel
Skillz price target lowered to $28 from $30 at Stifel
03/11/21 Canaccord
Skillz price target raised to $33 from $32 at Canaccord
02/25/21
Fly Intel: Top five analyst initiations
SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

  • 19
    Mar
SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

SKLZ Skillz
$16.62 /

-0.13 (-0.78%)

Recommendations
TAL Education price target lowered to $75 from $84 at Morgan Stanley » 06:48
04/23/21
04/23
06:48
04/23/21
06:48
TAL

TAL Education

$61.63 /

-1.42 (-2.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

04/15/21 CLSA
TAL Education transferred with an Outperform at CLSA
03/23/21 Citi
Citi downgrades TAL Education to Neutral, opens 'negative Catalyst Watch'
03/23/21 Citi
TAL Education downgraded to Neutral from Buy at Citi
01/28/21 Goldman Sachs
TAL Education downgraded to Neutral from Buy at Goldman Sachs
TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

Recommendations
Revance price target raised to $37 from $33 at Mizuho » 06:47
04/23/21
04/23
06:47
04/23/21
06:47
RVNC

Revance

$27.78 /

+0.36 (+1.31%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVNC Revance
$27.78 /

+0.36 (+1.31%)

RVNC Revance
$27.78 /

+0.36 (+1.31%)

02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
11/25/20 H.C. Wainwright
H.C. Wainwright keeps Buy rating on Revance, says FDA news 'not surprising'
RVNC Revance
$27.78 /

+0.36 (+1.31%)

RVNC Revance
$27.78 /

+0.36 (+1.31%)

Hot Stocks
Bristol-Myers announces EMA's CHMP recommends approval of Opdivo » 06:47
04/23/21
04/23
06:47
04/23/21
06:47
BMY

Bristol-Myers

$66.32 /

+ (+0.00%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

BMY Bristol-Myers
$66.32 /

+ (+0.00%)

Recommendations
Okta price target raised to $316 from $280 at KeyBanc » 06:46
04/23/21
04/23
06:46
04/23/21
06:46
OKTA

Okta

$275.10 /

+0.26 (+0.09%)

KeyBanc analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$275.10 /

+0.26 (+0.09%)

OKTA Okta
$275.10 /

+0.26 (+0.09%)

04/22/21
Fly Intel: Top five analyst initiations
04/22/21 Raymond James
Okta initiated with an Outperform at Raymond James
04/21/21 Raymond James
Okta initiated with an Outperform at Raymond James
04/09/21
Fly Intel: Top five analyst upgrades
OKTA Okta
$275.10 /

+0.26 (+0.09%)

OKTA Okta
$275.10 /

+0.26 (+0.09%)

OKTA Okta
$275.10 /

+0.26 (+0.09%)

OKTA Okta
$275.10 /

+0.26 (+0.09%)

Recommendations
Seagate price target raised to $98 from $90 at Morgan Stanley » 06:45
04/23/21
04/23
06:45
04/23/21
06:45
STX

Seagate

$84.14 /

+0.19 (+0.23%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

06:37 Today Citi
Seagate price target raised to $85 from $75 at Citi
04/21/21 Loop Capital
Seagate price target raised to $100 from $90 at Loop Capital
04/08/21 Morgan Stanley
Seagate price target raised to $90 from $86 at Morgan Stanley
03/22/21 Argus
Seagate price target raised to $86 from $75 at Argus
STX Seagate
$84.14 /

+0.19 (+0.23%)

  • 04
    Mar
STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

STX Seagate
$84.14 /

+0.19 (+0.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.